BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sakurai-Komada N, Iso H, Koike KA, Ikeda A, Umesawa M, Ikehara S, Inoue M, Tsugane S. Association between Chlamydophila pneumoniae infection and risk of coronary heart disease for Japanese: the JPHC study. Atherosclerosis. 2014;233:338-342. [PMID: 24530959 DOI: 10.1016/j.atherosclerosis.2014.01.023] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Yazouli LE, Hejaji H, Elmdaghri N, Alami AA, Dakka N, Radouani F. Investigation of Chlamydia pneumoniae infection in Moroccan patients suffering from cardiovascular diseases. J Infect Public Health 2018;11:246-9. [PMID: 28869155 DOI: 10.1016/j.jiph.2017.07.029] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
2 Chou HW, Wang JL, Chang CH, Lai CL, Lai MS, Chan KA. Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study. Clin Infect Dis 2015;60:566-77. [PMID: 25409476 DOI: 10.1093/cid/ciu914] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 7.4] [Reference Citation Analysis]
3 Ilmarinen P, Tuomisto LE, Kankaanranta H. Phenotypes, Risk Factors, and Mechanisms of Adult-Onset Asthma. Mediators Inflamm 2015;2015:514868. [PMID: 26538828 DOI: 10.1155/2015/514868] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 9.0] [Reference Citation Analysis]
4 Correale M, Tricarico L, Fortunato M, Dattilo G, Iacoviello M, Brunetti ND. Infection, atherothrombosis and thromboembolism beyond the COVID-19 disease: what similar in physiopathology and researches. Aging Clin Exp Res 2021;33:273-8. [PMID: 33449336 DOI: 10.1007/s40520-020-01775-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Lawson JS. Multiple Infectious Agents and the Origins of Atherosclerotic Coronary Artery Disease. Front Cardiovasc Med 2016;3:30. [PMID: 27672638 DOI: 10.3389/fcvm.2016.00030] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
6 Radouani F, El Yazouli L, Elyazghi Z, Hejaji H, Alami AA, Elmdaghri N. Chlamydia pneumoniae sero-prevalence in Moroccan patients with cardiovascular diseases. Infect Dis Health 2019;24:67-74. [PMID: 30541691 DOI: 10.1016/j.idh.2018.10.004] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Zheng N, Zhang L, Wang B, Wang G, Liu J, Miao G, Zhao X, Liu C, Zhang L. Chlamydia pneumoniae infection promotes vascular smooth muscle cell migration via c-Fos/interleukin-17C signaling. Int J Med Microbiol 2019;309:151340. [PMID: 31494039 DOI: 10.1016/j.ijmm.2019.151340] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Khoshbayan A, Taheri F, Moghadam MT, Chegini Z, Shariati A. The association of Chlamydia pneumoniae infection with atherosclerosis: Review and update of in vitro and animal studies. Microb Pathog 2021;154:104803. [PMID: 33609645 DOI: 10.1016/j.micpath.2021.104803] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Broker M, Frager SZ, Patel NS, Lebovics E, Frishman WH. The Inflammatory Relationship Between Hepatitis C Virus With Coronary and Carotid Atherosclerosis. Cardiol Rev 2021;29:178-83. [PMID: 32618587 DOI: 10.1097/CRD.0000000000000314] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Murthy AK, Li W, Ramsey KH. Immunopathogenesis of Chlamydial Infections. Curr Top Microbiol Immunol 2018;412:183-215. [PMID: 27370346 DOI: 10.1007/82_2016_18] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
11 Filardo S, Di Pietro M, Farcomeni A, Schiavoni G, Sessa R. Chlamydia pneumoniae-Mediated Inflammation in Atherosclerosis: A Meta-Analysis. Mediators Inflamm 2015;2015:378658. [PMID: 26346892 DOI: 10.1155/2015/378658] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
12 Di Pietro M, Filardo S, De Santis F, Mastromarino P, Sessa R. Chlamydia pneumoniae and oxidative stress in cardiovascular disease: state of the art and prevention strategies. Int J Mol Sci 2014;16:724-35. [PMID: 25561227 DOI: 10.3390/ijms16010724] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
13 Beaulieu LM, Clancy L, Tanriverdi K, Benjamin EJ, Kramer CD, Weinberg EO, He X, Mekasha S, Mick E, Ingalls RR, Genco CA, Freedman JE. Specific Inflammatory Stimuli Lead to Distinct Platelet Responses in Mice and Humans. PLoS One 2015;10:e0131688. [PMID: 26148065 DOI: 10.1371/journal.pone.0131688] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
14 Ampuero J, Romero-Gómez M. Assessing cardiovascular risk in hepatitis C: An unmet need. World J Hepatol. 2015;7:2214-2219. [PMID: 26380047 DOI: 10.4254/wjh.v7.i19.2214] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]